Get the Stockscreener App
2.815
1.43%
0.025
Cerus Corp stock is traded at $2.815, with a volume of 108.86K.
It is up +1.43% in the last 24 hours and down -9.29% over the past month.
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety, and generates revenue from the same.
See More
Previous Close:
$2.79
Open:
$2.81
24h Volume:
108.86K
Relative Volume:
0.04
Market Cap:
$570.32M
Revenue:
$216.56M
Net Income/Loss:
$-9.57M
P/E Ratio:
-56.64
EPS:
-0.0497
Net Cash Flow:
$-1.22M
1W Performance:
-5.03%
1M Performance:
-9.29%
6M Performance:
+17.43%
1Y Performance:
+135.83%
1-Day Range:
$2.80
$2.86
1-Week Range:
$2.76
$3.075
52-Week Range:
$1.17
$3.4698
Cerus Corp Stock (CERS) Company Profile
Name
Cerus Corp
Sector
Industry
Phone
(925) 288-6000
Address
1220 CONCORD AVENUE, CONCORD, CA
Compare CERS vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CERS
Cerus Corp
|
2.83 | 574.35M | 216.56M | -9.57M | -1.22M | -0.0497 |
ABT
Abbott Laboratories
|
114.75 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
330.90 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
92.36 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
49.62 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.50 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Cerus Corp Stock (CERS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-12-24 | Initiated | Craig Hallum | Buy |
| Jan-20-23 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-17-23 | Downgrade | Stephens | Overweight → Equal-Weight |
| Oct-08-20 | Resumed | BTIG Research | Buy |
| Jun-16-20 | Resumed | Cantor Fitzgerald | Overweight |
| Feb-26-20 | Initiated | BTIG Research | Buy |
| Nov-13-19 | Upgrade | BTIG Research | Neutral → Buy |
| Aug-28-19 | Initiated | Stifel | Buy |
| Aug-23-19 | Resumed | Stephens | Overweight |
| Jan-05-18 | Resumed | Cantor Fitzgerald | Overweight |
| Dec-08-17 | Resumed | BTIG Research | Neutral |
| Jul-07-16 | Resumed | Cantor Fitzgerald | Buy |
| Dec-17-15 | Downgrade | Wedbush | Outperform → Neutral |
| May-02-14 | Reiterated | MLV & Co | Buy |
| Apr-24-13 | Reiterated | Cantor Fitzgerald | Buy |
| Mar-15-13 | Reiterated | MLV & Co | Buy |
| Apr-17-12 | Initiated | Cantor Fitzgerald | Buy |
| Feb-29-12 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Nov-10-11 | Reiterated | MLV & Co | Buy |
| Jun-03-11 | Initiated | Wedbush | Outperform |
| Mar-04-11 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-09-10 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Aug-26-09 | Upgrade | Avondale | Mkt Perform → Mkt Outperform |
View All
Cerus Corp Stock (CERS) Latest News
CERS Initiates Coverage On Freedom Broker -- Price Target Announ - GuruFocus
Cerus: This Blood-Safety Underdog Should Be Earning More Respect (NASDAQ:CERS) - Seeking Alpha
Cerus Corp (CERS) Chief Legal Officer Chrystal Jensen Sells 30,0 - GuruFocus
Cerus Corp chief legal officer sells $89,529 in company stock. - Investing.com
Cerus Corp chief legal officer sells $89,529 in company stock. By Investing.com - Investing.com India
Cerus (CERS) legal chief sells 30,000 shares in preset plan - Stock Titan
Cerus (NASDAQ: CERS) insider moves to sell more stock after July sale - Stock Titan
Assenagon Asset Management S.A. Has $920,000 Stock Holdings in Cerus Corporation $CERS - MarketBeat
Cerus (NASDAQ:CERS) Downgraded by Wall Street Zen to Hold - MarketBeat
Baker Bros. cuts Cerus Corporation (CERS) position to 3.2% ownership stake - Stock Titan
Cerus Corp (CERS): ARK Investment, Catherine Wood report 8.95% ownership stake - Stock Titan
Cerus Corp (CERS) sees Soleus Capital group report 1.2% beneficial stake - Stock Titan
Wasatch Advisors LP Sells 1,897,237 Shares of Cerus Corporation $CERS - MarketBeat
Cerus Corp (CERS) Stock News Today - TradingKey
Cerus Corp (CERS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Cerus (CERS) Institutional Ownership 2026 $CERS - MarketBeat
Cerus Corporation Q2 2026 10-Q Report: Financial Statements, Risk Factors, and SEC Filings Overview - Minichart
CERS Looks 26.3% Overvalued on GF Value™ - GuruFocus
Cerus Q2 revenue rises to $63.3 million - Quiver Quantitative
Cerus reports Q2 2026 revenue $63.3M; product revenue $57.4M, raises 2026 product guidance - TradingView
Cerus: Q2 Earnings Snapshot - KING5.com
Cerus raises FY26 sales guidance to $229-231M as Q2 EPS meets estimates - scanx.trade
Cerus Corp expected to post a loss of 1 cent a shareEarnings Preview - TradingView
CERS|Cerus Corp|Price:3.065|Chg%:+0.135 - TradingKey
Cerus Corp (CERS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Cerus Corp (CERS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Cerus Corp (CERS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Cerus Corp (CERS) Cash Flow - TradingKey
Cerus Corp (CERS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Cerus Corp (CERS) Income Statement - TradingKey
Cerus Corp (CERS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
CERS|Cerus Corp|Price:2.845|Chg%:+0.135 - TradingKey
Cerus (CERS) to Announce Quarterly Earnings on Thursday - MarketBeat
AlTi Global Leads Our Selection Of 3 Promising Penny Stocks - simplywall.st
Cerus Corp (CERS) CEO trades 16666 shares under 10b5-1 plan - Stock Titan
Cerus Corporation (CERS) Edges Higher as Stock Holds Above Key SupportDiagonal Spread Trade - dars.gov.et
Cerus Corporation (NASDAQ:CERS) Short Interest Down 35.3% in June - MarketBeat
CERS: Cerus Corp. Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Press Release: Cerus Corporation to Release Second Quarter 2026 Financial Results on July 30, 2026 - Moomoo
Cerus Corporation to release Q2 2026 results on July 30 - scanx.trade
CERS shareholder (NASDAQ: CERS) details planned stock sales in 2026 - Stock Titan
Cerus to Discuss Results and Outlook in July 30 Webcast - Stock Titan
Cerus Corporation Announces Executive Chairman Transition and Employment Agreement Amendment – SEC 8-K Filing July 2026 - Minichart
Cerus Corporation (CERS) defines pay and term for William Greenman as Executive Chairman - Stock Titan
Cerus Corp faces a complex landscape as blood safety technology evolves - Ad-hoc-news.de
ETFs Investing in Cerus Corporation Stocks - TradingView
Cerus Corp updates focus on blood safety. Business model supports long-term growth - Ad-hoc-news.de
Cerus Corp looks to blood safety technology as investors weigh long-term growth - ad-hoc-news.de
Cerus Company Profile & Introduction - Moomoo
CERSCerus Corp Latest SEC Filings - Finviz
CERS Should I Buy - Intellectia AI
Cerus Corp Stock (CERS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.59%
0.75%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):